Seven-Year Follow-Up of the Phase III KEYNOTE-006 Study: Pembrolizumab Versus Ipilimumab in Advanced Melanoma
暂无分享，去创建一个
A. Ribas | J. Schachter | J. Grob | A. Daud | G. Long | C. McNeil | M. Lotem | M. Carlino | O. Hamid | M. Nyakas | C. Krepler | D. Kee | D. Grebennik | T. Petrella | A. Blaustein | A. Arance | C. Robert | J. Larkin | James Anderson